Skip to main content
. Author manuscript; available in PMC: 2016 Jan 16.
Published in final edited form as: Neurourol Urodyn. 2014 Oct 18;35(1):81–84. doi: 10.1002/nau.22684

Table I.

Outcomes in the ValUE trial (from Nager et al 2012)

OUTCOMES URODYNAMIC TESTING n=272 OFFICE EVALUATION ONLY n=266 P value
PRIMARY
70% reduction in Urogenital Distress Inventory Score-no.(%) 210 (77.2) 210 (78.9) 0.63
“very much better” or “much better” on Patient Global Impression of Improvement-no./total no.(%) 248/270 (91.9) 238/262 (90.8) 0.68
SECONDARY
Overall patient satisfaction score at 12 mo 79.5±30.4 82.2±28.6 0.28
Positive provocative stress test at 12 mo — no./total no. (%) 36/225 (16.0) 26/222 (11.7) 0.19